Orchestra BioMed Holdings, Inc.
OBIO
Cena:
$ 4.06
-0.04 (-0.98%)
Valuace
100
Růst
85
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
ORCHESTRA BIOMED ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
13-02-2026
NEW HOPE, PA., FEB. 13, 2026 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO) (“...
Více zde
ORCHESTRA BIOMED TO RECEIVE UP TO $21 MILLION IN PROCEEDS FROM ACQUISITION OF VIVASURE BY HAEMONETICS
12-01-2026
$11 MILLION IN PROCEEDS EXPECTED TO BE RECEIVED DURING 2026, WITH REMAINDER OF EXPECTED PROCEEDS TO ...
Více zde
ORCHESTRA BIOMED ANNOUNCES AVIM THERAPY AND VIRTUE SAB PROGRAM PRESENTATIONS AT ICI MEETING
08-12-2025
NEW HOPE, PA., DEC. 08, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
26-11-2025
NEW HOPE, PA., NOV. 26, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO) (“...
Více zde
ORCHESTRA BIOMED TO PARTICIPATE IN UPCOMING INSTITUTIONAL INVESTOR CONFERENCES
11-11-2025
NEW HOPE, PA., NOV. 11, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO) (“...
Více zde
ORCHESTRA BIOMED REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND HIGHLIGHTS RECENT BUSINESS UPDATES
10-11-2025
NEW HOPE, PA., NOV. 10, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED TO HOST BUSINESS UPDATE CALL ON NOVEMBER 12, 2025
03-11-2025
NEW HOPE, PA., NOV. 03, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO) (“...
Více zde
ORCHESTRA BIOMED AND TERUMO ENTER INTO NEW $30 MILLION VIRTUE SAB STRATEGIC AGREEMENTS
28-10-2025
NEW AGREEMENT GRANTS TERUMO VIRTUE SAB CORONARY INDICATION RIGHT OF FIRST REFUSAL AND SUPERSEDES PRI...
Více zde
ORCHESTRA BIOMED ANNOUNCES FIRST PATIENTS ENROLLED IN VIRTUE® SAB US PIVOTAL IDE CORONARY TRIAL
27-10-2025
NEW HOPE, PA., OCT. 27, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED TO SHOWCASE TRANSFORMATIVE POTENTIAL OF AVIM THERAPY IN KEYNOTE PRESENTATION ON HYPERTENSIVE HEART DISEASE AT GEORGIA INNOVATION SUMMIT
09-10-2025
PRESENTATION TO PROVIDE COMPREHENSIVE OVERVIEW OF AVIM THERAPY CLINICAL EVIDENCE DEMONSTRATING THE P...
Více zde
ORCHESTRA BIOMED PRESENTS NEW AVIM THERAPY CLINICAL DATA AT HRX DEMONSTRATING SUBSTANTIAL AND SUSTAINED BLOOD PRESSURE REDUCTIONS THAT ARE REPRODUCIBLE UPON REACTIVATION FOLLOWING WASHOUT
04-09-2025
NEW HOPE, PA., SEPT. 04, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “...
Více zde
ORCHESTRA BIOMED ANNOUNCES PUBLICATION OF CLINICAL DATA DEMONSTRATING FAVORABLE BLOOD PRESSURE AND HEMODYNAMIC EFFECTS OF AVIM THERAPY IN JACC: CLINICAL ELECTROPHYSIOLOGY
26-08-2025
NEW HOPE, PA., AUG. 26, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED ANNOUNCES PUBLICATION OF AVIM THERAPY CLINICAL DATA IN JACC: ADVANCES DEMONSTRATING POTENTIAL TO IMPROVE CARDIAC FUNCTION IN PATIENTS WITH HYPERTENSION AND DIASTOLIC DYSFUNCTION
14-08-2025
ECHOCARDIOGRAPHIC DATA ANALYSIS DEMONSTRATED FAVORABLE IMPACT OF ATRIOVENTRICULAR INTERVAL MODULATIO...
Více zde
ORCHESTRA BIOMED REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND HIGHLIGHTS RECENT BUSINESS UPDATES
12-08-2025
NEW HOPE, PA., AUG. 12, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED ANNOUNCES ROLLOUT OF FDA-APPROVED BACKBEAT GLOBAL PIVOTAL STUDY PROTOCOL UPDATE SIGNIFICANTLY EXPANDING PATIENT ELIGIBILITY
08-08-2025
NEW HOPE, PA., AUG. 08, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED SECURES OVER $111 MILLION IN PROCEEDS AND COMMITTED CAPITAL FOLLOWING COMPLETION OF STRATEGIC TRANSACTIONS AND CONCURRENT PUBLIC AND PRIVATE EQUITY OFFERINGS
05-08-2025
NEW HOPE, PA., AUG. 05, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED ANNOUNCES PRICING OF $40 MILLION PUBLIC OFFERING
01-08-2025
NEW HOPE, PA., AUG. 01, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED ANNOUNCES PROPOSED PUBLIC OFFERING
31-07-2025
NEW HOPE, PA., JULY 31, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED SHOWCASES AVIM THERAPY AS PURPOSE-BUILT SOLUTION FOR HYPERTENSIVE HEART DISEASE AT CSI FRANKFURT 2025
18-06-2025
NEW HOPE, PA., JUNE 18, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND HIGHLIGHTS RECENT REGULATORY AND CLINICAL MILESTONES
12-05-2025
NEW HOPE, PA., MAY 12, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “OR...
Více zde
ORCHESTRA BIOMED'S AVIM THERAPY GLOBAL INTELLECTUAL PROPERTY ESTATE REACHES 137 ISSUED PATENTS FOR THE TREATMENT OF HYPERTENSION AND HEART FAILURE
07-05-2025
NEW HOPE, PA., MAY 07, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO) (“O...
Více zde
ORCHESTRA BIOMED RECEIVES FDA APPROVAL OF IDE TO INITIATE U.S. CORONARY PIVOTAL TRIAL RANDOMIZING FIRST-IN-CLASS SIROLIMUS-ANGIOINFUSION BALLOON, VIRTUE SAB, HEAD-TO-HEAD WITH PACLITAXEL-COATED BALLOON
29-04-2025
ORCHESTRA BIOMED'S VIRTUE ® SIROLIMUS ANGIOINFUSION BALLOON™ (“VIRTUE SAB”) IS THE ONLY NO...
Více zde
ORCHESTRA BIOMED TO PARTICIPATE IN UPCOMING INSTITUTIONAL INVESTOR CONFERENCES
28-04-2025
NEW HOPE, PA., APRIL 28, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “...
Více zde
ORCHESTRA BIOMED ANNOUNCES AVIM THERAPY-FOCUSED SATELLITE SYMPOSIUM AT HRS 2025 ANNUAL MEETING
23-04-2025
FDA RECENTLY GRANTED BREAKTHROUGH DEVICE DESIGNATION TO AVIM THERAPY FOR USE IN PATIENTS WITH UNCONT...
Více zde
ORCHESTRA BIOMED RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR AVIM THERAPY
22-04-2025
NEW HOPE, PA., APRIL 22, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO) (...
Více zde
ORCHESTRA BIOMED REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES A FOURTH QUARTER BUSINESS UPDATE
31-03-2025
NEW HOPE, PA., MARCH 31, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “...
Více zde
ORCHESTRA BIOMED TO PRESENT AT UPCOMING INVESTOR CONFERENCES
20-02-2025
NEW HOPE, PA., FEB. 20, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED APPOINTS VIVEK REDDY, M.D. AS EXECUTIVE CHAIRMAN OF THE BACKBEAT STUDY STEERING COMMITTEE AND CHAIRMAN OF BIOELECTRONIC THERAPIES SCIENTIFIC ADVISORY BOARD
18-02-2025
NEW HOPE, PA., FEB. 18, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
ORCHESTRA BIOMED ANNOUNCES DATA DEMONSTRATING FAVORABLE IMPACT OF AVIM THERAPY ON DIASTOLIC DYSFUNCTION, A KEY DRIVER OF HEART FAILURE PROGRESSION, WILL BE PRESENTED AS LATE-BREAKING SCIENCE AT THE THT 2025 CONFERENCE
12-02-2025
NEW HOPE, PA., FEB. 12, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO) (“...
Více zde
ORCHESTRA BIOMED ANNOUNCES APPOINTMENT OF FORMER MEDTRONIC SVP OF CORPORATE DEVELOPMENT CHRISTOPHER CLEARY TO BOARD OF DIRECTORS
05-02-2025
NEW HOPE, PA., FEB. 05, 2025 (GLOBE NEWSWIRE) -- ORCHESTRA BIOMED HOLDINGS, INC. (NASDAQ: OBIO, “O...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2026-02-13 00:00:00 | 8-K |  | Stáhnout |
| 2026-01-12 00:00:00 | 8-K | | Stáhnout |
| 2025-11-13 00:00:00 | 8-K | | Stáhnout |
| 2025-11-10 00:00:00 | 10-Q | | Stáhnout |
| 2025-10-30 00:00:00 | 8-K | | Stáhnout |
| 2025-10-28 00:00:00 | 8-K | | Stáhnout |
| 2025-08-12 01:00:00 | 10-Q | | Stáhnout |
| 2025-08-12 00:00:00 | 10-Q | | Stáhnout |
| 2025-08-04 01:00:00 | 8-K | | Stáhnout |
| 2025-08-04 00:00:00 | 8-K | | Stáhnout |
| 2025-07-31 01:00:00 | 8-K | | Stáhnout |
| 2025-07-31 00:00:00 | 8-K | | Stáhnout |
| 2025-06-24 01:00:00 | 8-K | | Stáhnout |
| 2025-06-24 00:00:00 | 8-K | | Stáhnout |
| 2025-05-12 01:00:00 | 10-Q | | Stáhnout |
| 2025-05-12 00:00:00 | 10-Q | | Stáhnout |
| 2025-04-29 01:00:00 | 8-K | | Stáhnout |
| 2025-04-29 00:00:00 | 8-K | | Stáhnout |
| 2025-03-31 01:00:00 | 10-K | | Stáhnout |
| 2025-03-31 00:00:00 | 10-K | | Stáhnout |
| 2025-03-03 00:00:00 | 8-K | | Stáhnout |
| 2025-03-02 23:00:00 | 8-K | | Stáhnout |
| 2025-02-25 00:00:00 | 8-K | | Stáhnout |
| 2025-02-24 23:00:00 | 8-K | | Stáhnout |
| 2025-02-05 00:00:00 | 8-K | | Stáhnout |
| 2025-02-04 23:00:00 | 8-K | | Stáhnout |
| 2024-11-12 00:00:00 | 10-Q | | Stáhnout |
| 2024-11-11 23:00:00 | 10-Q | | Stáhnout |
| 2024-08-12 01:00:00 | 8-K | | Stáhnout |
| 2024-08-12 01:00:00 | 10-Q | | Stáhnout |
| 2024-08-12 00:00:00 | 8-K | | Stáhnout |
| 2024-08-12 00:00:00 | 10-Q | | Stáhnout |
| 2024-07-30 01:00:00 | 8-K | | Stáhnout |
| 2024-07-30 00:00:00 | 8-K | | Stáhnout |
| 2024-06-20 01:00:00 | 8-K | | Stáhnout |
| 2024-06-20 00:00:00 | 8-K | | Stáhnout |
| 2024-06-11 01:00:00 | 8-K | | Stáhnout |
| 2024-06-11 00:00:00 | 8-K | | Stáhnout |
| 2024-05-13 01:00:00 | 10-Q | | Stáhnout |
| 2024-05-13 00:00:00 | 10-Q | | Stáhnout |
| 2024-03-29 00:00:00 | 8-K | | Stáhnout |
| 2024-03-28 23:00:00 | 8-K | | Stáhnout |
| 2024-03-27 00:00:00 | 10-K | | Stáhnout |
| 2024-03-26 23:00:00 | 10-K | | Stáhnout |
| 2024-03-07 00:00:00 | 8-K | | Stáhnout |
| 2024-03-06 23:00:00 | 8-K | | Stáhnout |
